Norland Medical Systems of White Plains, NY, has completed the sale of its bone densitometry business to women's healthcare provider CooperSurgical. Norland received $3.5 million at closing and will receive an additional $1.5 million, pending post-closing adjustments and indemnities.
Norland will also receive additional payments based on net sales of certain products over a three-year period, up to a maximum total sales price of $12 million. After the close of the divestiture, Norland changed its name to Orthometrix, in recognition of its new focus on the musculoskeletal market.
By AuntMinnie.com staff writersApril 15, 2002
Related Reading
Norland to sell BMD business to CooperSurgical, February 28, 2002
Norland results ebb, November 14, 2001
Norland revenues slump in 2000, April 5, 2001
Norland, Marconi sign distribution agreement, January 15, 2001
CooperSurgical to distribute Norland bone measurement systems, November 7, 2000
Copyright © 2002 AuntMinnie.com
![Representative example of a 16-year-old male patient with underlying X-linked adrenoleukodystrophy. (A, B) Paired anteroposterior (AP) chest radiograph and dual-energy x-ray absorptiometry (DXA) report shows lumbar spine (L1 through L4) areal bone mineral density (BMD). The DXA report was reformatted for anonymization and improved readability. The patient had low BMD (Z score ≤ −2.0). (C) Model (chest radiography [CXR]–BMD) output shows the predicted raw BMD and Z score in comparison with the DXA reference standard, together with interpretability analyses using Shapley additive explanations (SHAP) and gradient-weighted class activation maps. The patient was classified as having low BMD, consistent with the reference standard. AM = age-matched, DEXA = dual-energy x-ray absorptiometry, RM2 = room 2, SNUH = Seoul National University Hospital, YA = young adult.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/04/ai-children-bone-density.0snnf2EJjr.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
